Hannah Lewis
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Hannah Lewis's research focuses on pediatric-onset multiple sclerosis. Her recent publication investigates the clinical and MRI outcomes of using first-line rituximab in this patient population. Lewis collaborates with researchers at the University of Arkansas for Medical Sciences, including Debopam Samanta, Raghu Ramakrishnaiah, Praveen Kumar Ramani, and Adrianne Parkey, with whom she has co-authored publications.
Metrics
- Publications: 1
Selected Publications
-
First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort (2026)
Collaboration Network
Top Collaborators
- First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort
- First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort
- First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort
- First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort
- First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort
- First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort
- First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort
Similar Researchers
Based on overlapping research topics